Evidence map›Paper›PMID 18446368›Full record

ArticleJournal of cancer research and clinical oncology2008

Germline mutations in the von Hippel-Lindau disease (VHL) gene in mainland Chinese families.

Jin Zhang, Yiran Huang, Jiahua Pan, Dongming Liu, Lixin Zhou, Wei Xue, Qi Chen, Baijun Dong, Hanqing Xuan

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Genetics educational needs in China: physicians' experience and knowledge of genetic testing.Genetics in medicine : official journal of the American College of Medical Genetics · 2015
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jin ZhangDepartment of Urology, Renji Hospital, Shanghai Jiaotong University School of Medicine, 1630 Dong Fang Road, 200127, Shanghai, People's Republic of China.
Yiran Huang
Jiahua Pan
Dongming Liu
Lixin Zhou
Wei Xue
Qi Chen
Baijun Dong
Hanqing Xuan
Shanghai Jiao Tong University · CNRenji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundvon Hippel-Lindau (VHL) disease is a hereditary cancer syndrome caused by germline mutations in the VHL gene. To date, more than 500 VHL families have been reported worldwide. However, few information is available about VHL germline mutations in mainland Chinese families.

objectiveTo provide some preliminary information about the germline VHL mutations in mainland Chinese population.

methodsA total of 27 index patients suspected of having VHL disease from unrelated Chinese families were studied by using direct DNA sequencing analysis and universal primer quantitative fluorescent multiplex polymerase chain reaction.

resultsThe VHL germline mutations were detected in 26 (96%) probands. A total of 20 intragenic mutations (77%) were identified consisting of 12 missenses, 5 nonsenses, 2 micro-deletions and 1 novel intron mutation (IVS1-38C>T). Six large deletions (23%) were detected including four partial deletions and two complete deletions. Furthermore, a C>T substitution at nucleotide 470 (Pro86Leu) was observed in two unrelated Chinese families. Of note, two mutations (Asn78Ser and Ser80Ile) previously characterized as VHL type I mutations in Western VHL were associated with the type II Chinese family. In addition, a VHL germline mutation was also identified in a proband who did not fulfill the clinical diagnostic criteria for VHL disease.

conclusionsThe spectrum of VHL germline mutations in mainland Chinese population is similar to that observed in Western population, and Genetic testing can be powerful in diagnosis and clinical management of VHL disease.

Indexed as

Germ-Line MutationAmino Acid SubstitutionAsian PeopleChinaDNAExonsFamilyFemaleGene AmplificationGene DeletionHumansMalePedigreePolymerase Chain ReactionPolymorphism, Single NucleotideSequence DeletionDNAVHL protein, humanVon Hippel-Lindau Tumor Suppressor Protein

Identifiers

PMID18446368
PMCPMC12161732
OpenAlexW2072783163

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.